| Literature DB >> 31883893 |
Xu-Dong Hou1, Xiao-Qing Guan2, Yun-Feng Cao3, Zi-Miao Weng1, Qing Hu4, Hai-Bin Liu5, Shou-Ning Jia6, Shi-Zhu Zang1, Qi Zhou1, Ling Yang4, Guang-Bo Ge7, Jie Hou8.
Abstract
Herbal medicines are frequently used for the prevention and treatment of obesity and obesity-related disorders. Our preliminary screening showed that St. John's Wort (SJW) displayed potent inhibition on pancreatic lipase (PL), a key hydrolase responsible for lipid digestion and absorption in mammals. Herein, the inhibition potentials and inhibitory mechanism of SJW extract and its major constituents on PL were fully investigated by a set of in vitro and in silico studies. The results clearly demonstrated that the naphthodianthrones, biflavones and most of flavonoids in SJW displayed strong to moderate inhibition on PL. Among all tested natural compounds, two naphthodianthrones (hypericin and pseudohypericin) and one biflavone (I3,II8-biapigenin) isolated from SJW exhibited potent PL inhibition activity, with the IC50 values of <1 μM. Inhibition kinetics analyses showed that hypericin, pseudohypericin and I3,II8-biapigenin inhibited PL via a mixed manner, while molecular dynamics simulations revealed that three newly identified PL inhibitors could bind on PL at both the catalytic cavity and the interface between colipase and the C-terminal domain of PL. Collectively, our findings suggested that part of major constituents in SJW displayed potent PL inhibition activities, which could be used as lead compounds for the development of novel PL inhibitors.Entities:
Keywords: Hypericin; I3,II8-biapigenin; Pancreatic lipase; Pseudohypericin; St. John's Wort
Mesh:
Substances:
Year: 2019 PMID: 31883893 DOI: 10.1016/j.ijbiomac.2019.12.231
Source DB: PubMed Journal: Int J Biol Macromol ISSN: 0141-8130 Impact factor: 6.953